Data Dashboard

HPV Vaccine Coverage Male/Female (adolescents age 13-17 years)

	Female 1-dose	Female Up-To-Date	Male 1-dose	Male Up-To-Date
Kansas	74.5%	59.4%	76.2%	61.3%
United States	78.5%	64.0%	75.1%	59.0%

HPV Vaccine Coverage Both Male and Female (adolescents age 13-17 years)

	Male and Female Up-To-Date
Kansas	60.4%
United States	61.4%

Key Vaccines Coverage
(combined 7-vaccine series for children 19-35 months | Tdap and menACWY for adolescents age 13-17 years | influenza for all persons over 6 months age)

	Combined 7- vaccine series*	Tdap	MenACWY	Influenza
Kansas	65.3%	88.6%	90.7%	47.6%
United States	73.9%	89.0%	88.4%	49.3%

*The combined 7-vaccine series (4:3:1:3*:3:1:4) includes ≥4 doses of DTaP, ≥3 doses of Polio, ≥1 dose of measles-containing vaccine, Hib full series, ≥3 HepB, ≥1 Var, and ≥4 PCV.

Sources
Human papillomavirus (HPV) vaccination coverage among adolescents 13-17 years by State, HHS Region, and the United States, National Immunization Survey-Teen (NIS-Teen), 2023

Combined 7-vaccine Series Vaccination coverage among children 19-35 months by State, HHS Region, and the United States, National Immunization Survey-Child (NIS-Child), 2021

Tetanus-diphtheria toxoids (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination coverage among adolescents 13-17 years by State, HHS Region, and the United States, National Immunization Survey-Teen (NIS-Teen), 2023

Meningococcal conjugate (MenACWY) vaccination coverage among adolescents 13-17 years by State, HHS Region, and the United States, National Immunization Survey-Teen (NIS-Teen), 2023

Influenza vaccination coverage estimates for persons 6 months and older by state, HHS region, and the United States, National Immunization Survey-Flu (NIS-Flu) and Behavioral Risk Factor Surveillance System (BRFSS), 2022-23 influenza season

Up-To-Date HPV Vaccination Coverage Among Adolescents Aged 13-17 Years

Estimated 3-dose HPV Vaccine Coverage Among Adolescents Aged 13-17 Years Graph

	Female		Male		Both Male & Female
	1-dose	Up-To-Date	1-dose	Up-To-Date	Up-To-Date
Kansas	73.5%	61.9%	73.4%	59.5%	60.7%
United States	77.8%	64.6%	74.4%	60.6%	62.6%
HP2030 Target	-	80.0%	-	80.0%	80.0%

Estimated 1-dose HPV Vaccine Coverage Among Adolescents Aged 13-17 Years Graph

Human papillomavirus (HPV) vaccination coverage among adolescents 13-17 years by State, HHS Region, and the United States, National Immunization Survey-Teen (NIS-Teen), 2023 Human Papillomavirus (HPV) vaccination coverage (1 dose or more) among adolescents aged 13-17 years in the United States, by area and parental report of provider recommendation status, National Immunization Survey-Teen (NIS-Teen), United States, 2018-2022

	MenACWY
Kansas	90.7%
United States	88.4%
Target	80.0%

Estimated Tdap Vaccination Coverage Among Adolescents 13-17 Years

	Tdap
Kansas	88.6%
United States	89.0%
Target	90.0%

Tetanus-diphtheria toxoids (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination coverage among adolescents 13-17 years by State, HHS Region, and the United States, National Immunization Survey-Teen (NIS-Teen), 2023

	Children Age Group (Years)
	6 mo - 4 yrs	5-12 yr	13-17 yr
Kansas	63.4%	51.2%	34.8%
United States	64.2%	57.0%	46.9%
Target	70%	70%	70%

	Age Group (Years)
	18+	18-64	65+
Kansas	45.9%	38.7%	69.6%
United States	44.9%	37.0%	69.7%
HP2020 Target	70%	70%	70%

		Kansas
Race	White, Non-Hispanic	46.7%
Black, Non-Hispanic	42.6%
Other/Multi-Race, Non-Hispanic	47.8%
Ethnicity	Hispanic	44.4%

Estimated Vaccination Coverage for Recommended Vaccines to be Completed by Age 24 Months graph

	4+DTaP	3+Polio	1+MMR	3+Hib	3+HepB	1+Var	4+PCV	2+HepA	Rotavirus
Kansas	80.7%%	90.9%	92.7%	91.4%	91.6%	90.8%	87.6%	60%	72.6%
United States	79.1%	91.9%	90.6%	90.1%	91.1%	90.1%	80.8%	44.3%	75.4%

	Hib-FS	3+HepB	1+Var
Kansas	84%	95%	92%
United States	84%	94%	94%

	4+PCV	2+HepA	Rotavirus
Kansas	86%	80%	81%
United States	86%	78%	77%

ChildVaxView

Estimated pneumococcal vaccination among adults graph

	Age Group (Years)
	18-64yrs (At risk)	65+yrs
Kansas	34%	73%
United States	31%	70%
HP2020 Target	60%	90%

* - At risk individuals: Individuals who have self-reported having one or more of the following: 1 )having current asthma; 2)ever being told by a health professional they have diabetes, myocardial infarction, angina or coronary heart disease; 3) being a current smoker; or 4) ever being told by a health professional they have chronic obstructive pulmonary disease, emphysema or chronic bronchitis, or cancer (excluding skin cancer).

Pneumococcal vaccination coverage among adults 18-64 years at increased risk and ≥65 years, Td and Tdap vaccination coverage among adults ≥18 years, and shingles vaccination among adults ≥60 years, by State, HHS Region, and the United States, BRFSS, 2022

The Kansas Department of Health and Environment conducts Immunization Coverage Assessments into the statewide vaccination records of various age groups across the state. The reports aim to provide an understanding of the vaccination coverages in the state and how they compare to the recommendations by the Advisory Committee for Immunization Practices (ACIP) and the American College Health Association (ACHA). A primary benefit to these reports is the ability to see vaccination coverage at a local level (e.g. by county), which is not possible through national resources. Click on the links below to view a highlight of the respective report's data, and a link report itself.

Kindergarten Immunization
Coverage Survey
Kansas Measles Outbreak
Data

2023-24 Kindergarten Immunization Coverage Survey

Dashboard:

KDHE Kindergarten Immunization Dashboard

Overview:

The Kindergarten Immunization Dashboard shows data from the Kindergarten Immunization Coverage Survey. The survey is a collection of vaccination records for children enrolled in a kindergarten class at Kansas public and private schools during the school year. Statewide vaccination coverage levels are calculated and various factors assessed. This study includes children between the ages of five and seven.

2025 Measles Outbreak Data

With the rising outbreaks of measles across the United States, it's crucial to stay alert and informed. Understanding measles, its symptoms, and how to stay protected is essential for keeping our communities safe. Visit IKC's Measles/MMR Vaccine Resource Hub for more information on the Measles outbreak and how to stay protected.

See CDC's Measles Cases and Outbreaks page for national data of confirmed measles cases for the ongoing measles outbreak.

Also see KDHE's 2025 Kansas Measles Case Data Dashboard for updated information on the ongoing measles outbreak in Kansas.

Data Dashboard

HPV Vaccine Coverage Male/Female (adolescents age 13-17 years)

HPV Vaccine Coverage Both Male and Female (adolescents age 13-17 years)

Key Vaccines Coverage
(combined 7-vaccine series for children 19-35 months | Tdap and menACWY for adolescents age 13-17 years | influenza for all persons over 6 months age)

Contact Us:

Immunize Kansas Coalition:

Data Dashboard

HPV Vaccine Coverage Male/Female (adolescents age 13-17 years)

HPV Vaccine Coverage Both Male and Female (adolescents age 13-17 years)

Key Vaccines Coverage (combined 7-vaccine series for children 19-35 months | Tdap and menACWY for adolescents age 13-17 years | influenza for all persons over 6 months age)

Contact Us:

Immunize Kansas Coalition:

Social:

Key Vaccines Coverage
(combined 7-vaccine series for children 19-35 months | Tdap and menACWY for adolescents age 13-17 years | influenza for all persons over 6 months age)